ANIX

NASDAQ open

Anixa Biosciences

2.43 USD
▼-0.17-6.54%
盘后 3.03 0.00%
2026-11-20
市值
$84.82M
市盈率
—
EPS
-0.31
股息率
—
52 周区间
2.32 – 5.46
成交量
126.87K
Beta
0.45
目标价
9.67
52W 低 2.3252W 高 5.46
价格走势

公司简介

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to addr...